Manufacturer
ALLERGAN PHARMACEUTICALS IRELAND
Contents
Dexamethasone
Indication
Macular oedema secondary to retinal vein occlusion; Diabetic macular oedema; Uveitis As intravitreal implant containing 700 mcg injected into the affected eye Retreat after approx 6 months in cases of loss or decrease in vision and/or increase in retinal thickness. Inflammatory eye disorders as 0.1% solution: Instill 1 drop 4-6 times/day. Severe conditions: Instill 1 drop hourly, then reduced to 1 drop 4 hourly as the inflammation subsides.
Instruction
Diabetic macular oedema, Macular oedema secondary to retinal vein occlusion, Uveitis
Adult: As intravitreal implant containing 700 mcg injected into the affected eye. Retreat after approx 6 months in cases of loss or decrease in vision and/or increase in retinal thickness.
Inflammatory eye disorders
Adult: As 0.1% solution: Instill 1 drop 4-6 times daily. Severe conditions: Instill 1 drop hourly, then reduced to 1 drop 4 hourly as the inflammation subsides.
Drug interaction
Consult your pharmacist or physician.Keep a list of all your medications with you, and share the list with your doctor and pharmacist.
Malaysia
